Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK
Open Access
- 28 September 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1199
Abstract
Malaria-associated acute respiratory distress syndrome (MA-ARDS) is an often lethal complication of malaria. Currently, no adequate therapy for this syndrome exists. Although glucocorticoids (GCs) have been used to improve clinical outcome of ARDS, their therapeutic benefits remain unclear. We previously developed a mouse model of MA-ARDS, in which dexamethasone treatment revealed glucocorticoid resistance. In the present study, we investigated glucocorticoid sensitivity of mouse microvascular lung endothelial cells stimulated with interferon-g (IFN-g) and Plasmodium berghei NK65 (PbNK65). Upon challenge with IFN-g alone, dexamethasone inhibited the expression of CCL5 (RANTES) by 90% and both CCL2 (MCP-1) and CXCL10 (IP-10) by 50%. Accordingly, whole transcriptome analysis revealed that dexamethasone differentially affected several gene clusters and in particular inhibited a large cluster of IFN-g-induced genes, including chemokines. In contrast, combined stimulation with IFN-g and PbNK65 extract impaired inhibitory actions of glucocorticoids on chemokine release, without affecting the capacity of the glucocorticoid receptor to accumulate in the nucleus. Subsequently, we investigated the effects of glucocorticoids on two signaling pathways activated by IFN-g. Dexamethasone left phosphorylation and protein levels of signal transducer and activator of transcription 1 (STAT1) unhampered. In contrast, dexamethasone inhibited the IFN-g-induced activation of two mitogen-activated protein kinases (MAPK), JNK and p38. However, PbNK65 extract abolished the inhibitory effects of glucocorticoids on MAPK signaling, inducing glucocorticoid resistance. These data provide novel insights into the mechanisms of glucocorticoid actions in endothelial cells and show how malaria may impair the beneficial effects of glucocorticoids.Keywords
This publication has 86 references indexed in Scilit:
- Ligand-Induced Repression of the Glucocorticoid Receptor Gene Is Mediated by an NCoR1 Repression Complex Formed by Long-Range Chromatin Interactions with Intragenic Glucocorticoid Response ElementsMolecular and Cellular Biology, 2013
- Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoidsProceedings of the National Academy of Sciences, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Coactivation of GR and NFKB alters the repertoire of their binding sites and target genesGenome Research, 2011
- Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in MiceJournal of Biological Chemistry, 2011
- Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor BindingMolecular Cell, 2011
- Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor–induced STAT1 activationProceedings of the National Academy of Sciences, 2011
- Cellular Processing of the Glucocorticoid Receptor Gene and Protein: New Mechanisms for Generating Tissue-specific Actions of GlucocorticoidsJournal of Biological Chemistry, 2011
- Lysine 419 targets human glucocorticoid receptor for proteasomal degradationSteroids, 2010
- The Type I Interferon Signaling Pathway Is a Target for Glucocorticoid InhibitionMolecular and Cellular Biology, 2010